A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis

被引:121
作者
Alfonso, F
Zueco, J
Cequier, A
Mantilla, R
Bethencourt, A
López-Minguez, JR
Angel, J
Augé, JM
Gómez-Recio, M
Morís, C
Seabra-Gomes, R
Perez-Vizcayno, MJ
Macaya, C
机构
[1] Hosp Univ San Carlos, Serv Cardiol Intervencionist, Inst Cardiovasc, Unidad Hemodinam, Madrid 28040, Spain
[2] Univ Hosp Marques Valdecilla, Santander, Spain
[3] Univ Hosp Bellvitge, Barcelona, Spain
[4] Meixoeiro Hosp, Vigo, Spain
[5] Univ Hosp Son Dureta, Palma de Mallorca, Spain
[6] Univ Hosp Infanta Cristina, Badajoz, Spain
[7] Univ Hosp Valle Hebron, Barcelona, Spain
[8] Univ Hosp Santa Cruz & San Pablo, Barcelona, Spain
[9] Univ Hosp La Princesa, Madrid, Spain
[10] Univ Hosp Cent Asturias, Oviedo, Spain
[11] Univ Hosp Santa Cruz, Lisbon, Portugal
关键词
D O I
10.1016/S0735-1097(03)00852-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This randomized trial compared repeat stenting with balloon angioplasty (BA) in patients with in-stent restenosis (ISR). BACKGROUND Stent restenosis constitutes a therapeutic challenge. Repeat coronary interventions are currently used in this setting, but the recurrence risk remains high. METHODS We randomly assigned 450 patients with ISR to elective stent implantation (224 patients) or conventional BA (226 patients). Primary end point was recurrent restenosis rate at six months. Secondary end points included minimal lumen diameter (MLD), prespecified subgroup analyses, and a composite of major adverse events. RESULTS Procedural success was similar in both groups, but in-hospital complications were more frequent in the balloon group. After the procedure MLD was larger in the stent group (2.77 +/- 0.4 vs. 2.25 +/- 0.5 mm, p < 0.001). At follow-up, MLD was larger after stenting when the in-lesion site was considered (1.69 +/- 0.8 vs. 1.54 +/- 0.7 mm, p = 0.046). However, the binary restenosis rate (38% stent group, 39% balloon group) was similar with the two strategies. One-year event-free survival (follow-up 100%) was also similar in both groups (77% stent vs. 71% balloon, p = 0.19). Nevertheless, in the prespecified subgroup of patients with large vessels ( 3 mm) the restenosis rate (27% vs. 49%, p = 0.007) and the event-free survival (84% vs. 62%, p = 0.002) were better after repeat stenting. CONCLUSIONS In patients with ISR, repeat coronary stenting provided better initial angiographic results but failed to improve restenosis rate and clinical outcome when compared with BA. However, in patients with large vessels coronary stenting improved the long-term clinical and angiographic outcome. (C) 2003 by the American College Cardiology Foundation.
引用
收藏
页码:796 / 805
页数:10
相关论文
共 37 条
[1]   Cutting balloon angioplasty for the treatment of in-stent restenosis: A matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty [J].
Adamian, M ;
Colombo, A ;
Briguori, C ;
Nishida, T ;
Marsico, F ;
Di Mario, C ;
Albiero, R ;
Moussa, I ;
Moses, JW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (03) :672-679
[2]   Fate of stent-related side branches after coronary intervention in patients with in-stent restenosis [J].
Alfonso, F ;
Hernández, C ;
Pérez-Vizcayno, MJ ;
Hernández, R ;
Fernández-Ortíz, A ;
Escaned, J ;
Bañuelos, C ;
Sabaté, M ;
Sanmartín, M ;
Fernández, C ;
Macaya, C .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (05) :1549-1556
[3]   Stenting the stent:: Initial results and long-term clinical and angiographic outcome of coronary stenting for patients with in-stent restenosis [J].
Alfonso, F ;
Cequier, A ;
Zueco, J ;
Morís, C ;
Suárez, CP ;
Colman, T ;
Esplugas, E ;
Pérez-Vizcayno, MJ ;
Fernández, C ;
Macaya, C .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (03) :327-332
[4]   Long-term outcome and determinants of event-free survival in patients treated with balloon angioplasty for in-stent restenosis [J].
Alfonso, F ;
Pérez-Vizcayno, MJ ;
Hernández, R ;
Goicolea, J ;
Fernández-Ortíz, A ;
Escaned, J ;
Bañuelos, C ;
Fernández, C ;
Macaya, C .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (08) :1268-+
[5]   The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].
Altman, DG ;
Schulz, KF ;
Moher, D ;
Egger, M ;
Davidoff, F ;
Elbourne, D ;
Gotzsche, PC ;
Lang, T .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694
[6]   Subgroup analysis and other (mis)uses of baseline data in clinical trials [J].
Assmann, SF ;
Pocock, SJ ;
Enos, LE ;
Kasten, LE .
LANCET, 2000, 355 (9209) :1064-1069
[7]   MANAGEMENT OF RESTENOSIS WITHIN THE PALMAZ-SCHATZ CORONARY STENT (THE UNITED-STATES MULTICENTER EXPERIENCE) [J].
BAIM, DS ;
LEVINE, MJ ;
LEON, MB ;
LEVINE, S ;
ELLIS, SG ;
SCHATZ, RA .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (04) :364-366
[8]  
Bauters C, 1998, CIRCULATION, V97, P318
[9]   In-stent restenosis: Long-term outcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty [J].
Bossi, I ;
Klersy, C ;
Black, AJ ;
Cortina, R ;
Choussat, R ;
Cassagneau, B ;
Jordan, C ;
Laborde, JC ;
Laurent, JP ;
Bernies, M ;
Fajadet, J ;
Marco, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (06) :1569-1576
[10]  
BUYSE ME, 1989, CONTROL CLIN TRIALS, V10, pS187